To identify cancer-specific CTCF binding patterns, we surveyed six cancer types: T cell acute lymphoblastic leukemia (T-ALL), acute myeloid leukemia (AML), breast cancer (BRCA), colorectal cancer (CRC), lung cancer (LUAD), and prostate cancer (PRAD). Here, CTCF is linked to lung carcinoma.